Technical Trend Overview and Price Movement
On 7 July 2026, Abbott India’s share price closed at ₹26,851.80, marking a significant day change of +3.87% from the previous close of ₹25,850.45. The stock traded within a range of ₹25,950.35 to ₹27,019.90, demonstrating intraday volatility but ultimately closing near the upper end of the day’s spectrum. This price action reflects a short-term bullish momentum, yet the overall technical trend remains mildly bearish, signalling cautious optimism among traders.
The stock’s 52-week high stands at ₹35,280.00, while the 52-week low is ₹25,164.00, indicating that current prices are closer to the lower end of the annual range. This proximity to the yearly low suggests that while there is some recovery, the stock has yet to regain its previous highs, underscoring the importance of technical indicators in assessing future direction.
MACD and Momentum Indicators
The Moving Average Convergence Divergence (MACD) indicator presents a nuanced view. On a weekly basis, the MACD is mildly bullish, signalling that short-term momentum is improving and that buyers are gaining some control. However, the monthly MACD remains bearish, indicating that the longer-term trend is still under pressure. This divergence between weekly and monthly MACD readings suggests that while there may be short-term rallies, the broader downtrend has not yet been decisively reversed.
Complementing this, the Know Sure Thing (KST) indicator aligns with the MACD’s message: mildly bullish on the weekly chart but bearish on the monthly timeframe. This reinforces the notion that momentum is improving in the near term but remains subdued over a longer horizon.
RSI and Overbought/Oversold Conditions
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This absence of an overbought or oversold condition implies that the stock is not experiencing extreme buying or selling pressure at present. For investors, this neutrality in RSI suggests that the stock could be poised for either a continuation of the current mild recovery or a potential reversal, depending on forthcoming market catalysts.
Moving Averages and Bollinger Bands
Daily moving averages indicate a mildly bearish trend, reflecting that the stock price remains below key short-term averages, which often act as resistance levels. This technical setup suggests that while there is some upward price movement, the stock has yet to establish a firm foothold above these averages to confirm a sustained uptrend.
In contrast, Bollinger Bands provide a more optimistic signal on the weekly timeframe, showing a bullish pattern. The stock price is approaching the upper band, which often indicates increased buying interest and potential for further gains. However, the monthly Bollinger Bands remain mildly bearish, consistent with the longer-term caution expressed by other indicators.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Volume and Dow Theory Signals
On-Balance Volume (OBV) indicators on both weekly and monthly charts show no discernible trend, indicating that volume is not strongly confirming price movements. This lack of volume confirmation often signals caution, as price advances without volume support may lack conviction.
Dow Theory analysis reveals a mildly bearish trend on the weekly chart, with no clear trend on the monthly timeframe. This suggests that while short-term price action is tentative, the longer-term market structure remains uncertain, requiring investors to monitor for clearer directional cues.
Comparative Performance Against Sensex
Abbott India’s recent returns relative to the Sensex provide additional context for its technical signals. Over the past week, Abbott India outperformed the Sensex with a 6.13% gain compared to the benchmark’s 2.03%. However, over the past month, the stock’s 3.21% return lagged behind the Sensex’s 5.44%. Year-to-date, Abbott India has declined by 7.63%, slightly outperforming the Sensex’s 8.14% fall.
Longer-term returns show a mixed picture: a 1-year loss of 22.62% significantly underperforms the Sensex’s 6.17% decline, while over three years, Abbott India’s 12.98% gain trails the Sensex’s 19.00%. Notably, over five and ten years, Abbott India has outperformed the Sensex with returns of 55.93% and 470.16% respectively, highlighting its strong historical growth despite recent volatility.
Mojo Score and Analyst Ratings
MarketsMOJO assigns Abbott India a Mojo Score of 42.0, categorising it as a Sell with a recent downgrade from Hold on 12 May 2026. This downgrade reflects the deteriorating technical and fundamental outlook, signalling caution for investors. The stock is classified as a mid-cap within the Pharmaceuticals & Biotechnology sector, which has faced sector-wide pressures amid regulatory and market challenges.
Holding Abbott India Ltd. from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Investor Takeaway and Outlook
Abbott India’s technical landscape is characterised by a cautious shift from bearish to mildly bearish momentum, with short-term indicators showing tentative bullishness while longer-term signals remain subdued. The divergence between weekly and monthly MACD and KST readings, combined with neutral RSI and mixed Bollinger Bands, suggests that investors should remain vigilant for confirmation of trend reversals before committing to significant positions.
The stock’s recent outperformance relative to the Sensex over the past week is encouraging, but underperformance over longer periods and the downgrade in Mojo Grade to Sell highlight ongoing challenges. The absence of volume confirmation and the mildly bearish daily moving averages further reinforce the need for prudence.
For investors focused on the Pharmaceuticals & Biotechnology sector, Abbott India’s current technical profile suggests a wait-and-watch approach, monitoring for sustained price moves above key moving averages and stronger volume support. Given the mixed signals, a balanced strategy incorporating risk management and peer comparison is advisable.
Historical Performance Context
Despite recent volatility, Abbott India’s long-term performance remains impressive, with a ten-year return of 470.16% significantly outpacing the Sensex’s 188.16%. This track record underscores the company’s resilience and growth potential, which may appeal to investors with a longer investment horizon willing to navigate short-term fluctuations.
However, the sharp 22.62% decline over the past year relative to the Sensex’s 6.17% fall signals sector-specific or company-specific headwinds that require careful analysis before increasing exposure.
Conclusion
In summary, Abbott India Ltd. is at a technical crossroads, with momentum indicators signalling a mild improvement but longer-term trends still under pressure. The stock’s recent price gains and weekly bullish signals offer some optimism, yet the broader technical and fundamental context advises caution. Investors should closely monitor technical developments, particularly moving averages and volume trends, while considering the company’s downgraded Mojo Grade and sector dynamics before making investment decisions.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
